Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Chenmeizi Liang"'
Autor:
Yuanjin Zhang, Junze Huang, Shengbo Huang, Jie Liu, Luyao Deng, Chenmeizi Liang, Yuanqing Guo, Bingyi Yao, Xin Wang
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 14, Iss 4, Pp 1592-1604 (2024)
Organic anion-transporting polypeptides 1B1 (OATP1B1) plays a crucial role in the transport of statins. However, there are too few animal models related to OATP1B1, especially humanized animal models. In this study, the human SLCO1B1 cDNA was inserte
Externí odkaz:
https://doaj.org/article/e5278a73392e48af84ff4437c01b56b1
Publikováno v:
Drug Delivery, Vol 24, Iss 1, Pp 1453-1459 (2017)
Breast cancer resistance protein (BCRP), a key drug efflux transporter, significantly affects the therapeutic efficacy of many drugs. Thus, screening specific BCRP inhibitors and distinguishing between substrates and non-substrates of BCRP are valuab
Externí odkaz:
https://doaj.org/article/69640e02a2424556afe3183fcd44caf0
Autor:
Xin Wang, Xueyun Ma, Yuanjin Zhang, Yongmei Li, Junfang Zhao, Jian Lu, Mingyao Liu, Xuyang Shang, Xinrun Ma, Chenmeizi Liang
Publikováno v:
Drug Metabolism and Disposition. 47:71-79
Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein-9 nuclease (Cas9) technology is widely used as a tool for gene editing in rat genome site-specific engineering. Multidrug resistance 1 [MDR1 (also known as P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b99086ed13ccdf0f2a6057c5fe2453d
https://doi.org/10.1124/dmd.118.084277
https://doi.org/10.1124/dmd.118.084277
Publikováno v:
Drug Delivery
article-version (VoR) Version of Record
Drug Delivery, Vol 24, Iss 1, Pp 1453-1459 (2017)
article-version (VoR) Version of Record
Drug Delivery, Vol 24, Iss 1, Pp 1453-1459 (2017)
Breast cancer resistance protein (BCRP), a key drug efflux transporter, significantly affects the therapeutic efficacy of many drugs. Thus, screening specific BCRP inhibitors and distinguishing between substrates and non-substrates of BCRP are valuab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a601e5a6c2adb68d5d1e29a480693485
http://europepmc.org/articles/PMC8241135
http://europepmc.org/articles/PMC8241135
Autor:
Chenmeizi, Liang, Junfang, Zhao, Jian, Lu, Yuanjin, Zhang, Xinrun, Ma, Xuyang, Shang, Yongmei, Li, Xueyun, Ma, Mingyao, Liu, Xin, Wang
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals. 47(2)
Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein-9 nuclease (Cas9) technology is widely used as a tool for gene editing in rat genome site-specific engineering. Multidrug resistance 1 [MDR1 (also known as P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ec63b1df8f485bcbff24d18efc10ceb4
https://pubmed.ncbi.nlm.nih.gov/30478157
https://pubmed.ncbi.nlm.nih.gov/30478157
Publikováno v:
Regulatory Toxicology and Pharmacology. 108:104449
Multidrug resistance associated protein 2 (MRP2) is an important efflux transporter involved in clinical drug disposition and drug-drug interactions. The study of MRP2-mediated drug transport has become an integral part of drug discovery and developm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd0796745f670d4b55a1277fee30bd07
https://doi.org/10.1016/j.yrtph.2019.104449
https://doi.org/10.1016/j.yrtph.2019.104449